|
Market Closed -
Nasdaq
00:00:00 22/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 11.18 USD | -1.93% |
|
+1.18% | -45.09% |
| 09-29 | Keros Therapeutics Expects $20 Million Milestone Payment From Takeda | MT |
| 09-29 | Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.93% | +1.18% | -2.61% | +5.77% | -45.09% | -27.45% | -60.55% | -70.77% | - | 222M | |
| -0.21% | -4.43% | -12.27% | +16.53% | +62.57% | +44.40% | +74.13% | +4.36% | - | 66.22B | |
| -2.80% | +0.13% | -11.20% | +0.16% | +5.97% | +7.11% | +68.46% | +204.33% | +5,238.02% | 55.2B | |
| +0.13% | +3.97% | +11.55% | +17.04% | +16.73% | +12.11% | +91.64% | -16.85% | +247.43% | 52.79B | |
| +3.28% | +5.58% | +2.50% | +37.20% | +22.72% | +26.51% | +50.05% | +8.55% | +273.72% | 45.53B | |
| +0.51% | +9.95% | +5.69% | +21.27% | +27.20% | +22.40% | +133.92% | +2.98% | +1,066.50% | 43.94B | |
| -1.15% | +0.39% | +0.79% | +6.00% | +143.92% | +263.21% | +594.60% | +610.87% | - | 41.64B | |
| +0.10% | +9.90% | +8.93% | +15.15% | +14.63% | +16.11% | +59.33% | +10.50% | +165.28% | 34B | |
| -8.70% | -7.32% | -14.38% | +16.07% | +43.38% | +25.85% | -2.32% | -60.21% | - | 25.84B | |
| -0.69% | +2.81% | +14.09% | +36.05% | +28.27% | +35.42% | +25.42% | -13.07% | +127.27% | 23.51B | |
| +0.13% | +2.97% | -6.85% | -1.13% | -4.11% | -14.59% | +0.42% | -68.12% | - | 22.93B | |
| -1.70% | -3.83% | -22.28% | -13.42% | -45.97% | -43.11% | +274.96% | +241.72% | +569.80% | 20.54B | |
| +6.43% | +7.44% | +6.13% | +24.60% | +17.95% | +21.41% | +188.98% | +256.11% | +2,016.55% | 18.49B | |
| +0.30% | +5.89% | +12.86% | +15.07% | +47.34% | +78.74% | +205.92% | +202.77% | +458.65% | 16B | |
| +1.51% | +3.79% | +4.05% | +16.41% | +31.67% | +30.25% | +74.25% | -20.16% | +91.90% | 15.76B | |
| +1.95% | +5.24% | +0.55% | -6.39% | - | - | - | - | - | 15.69B | |
| +9.33% | +14.20% | +23.60% | +57.19% | +72.88% | +83.19% | +86.00% | -17.34% | +319.91% | 16.46B | |
| +1.73% | -1.26% | +2.17% | 0.00% | +177.32% | +151.62% | +366.59% | +1,443.68% | +750.84% | 15.01B | |
| -5.28% | +2.28% | -8.53% | -13.27% | +14.33% | -1.10% | +522.35% | - | - | 14.41B | |
| +6.35% | +9.63% | +9.26% | +11.18% | +1.66% | -4.14% | -18.29% | -33.15% | +119.13% | 14.29B | |
| Average | +0.44% | +4.02% | +1.20% | +13.07% | +33.34% | +38.31% | +143.99% | +149.23% | +880.38% | 27.92B | |
| Weighted average by Cap. | +0.07% | +3.80% | +0.08% | +14.54% | +37.76% | +43.57% | +141.48% | +126.97% | +1,200.90% |
- Stock Market
- Stocks
- KROS Stock
- Sector Keros Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
